Novo Nordisk, GSK pause some Twitter ad spending after Musk takeover
Eli Lilly isn’t the only pharma company that’s paused advertising on Twitter in recent days.
Novo Nordisk, one of the three major insulin drugmakers along with Lilly and Sanofi, has halted paid advertising on the social media site, Endpoints News has learned. Additionally, GSK has enacted a partial pause of Twitter advertising, stopping ads for specific products but continuing to run “corporate” advertisements.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,600+ biopharma pros reading Endpoints daily — and it's free.